1 / 26

Intraarterial thrombolytic treatment

Intraarterial thrombolytic treatment. Masoud Mehrpour M.D. Time is brain. Core. Ischemic penumbra. THE PENUMBRA CONCEPT.

robbin
Download Presentation

Intraarterial thrombolytic treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intraarterial thrombolytic treatment MasoudMehrpour M.D.

  2. Time is brain

  3. Core Ischemicpenumbra THE PENUMBRA CONCEPT The concept of penumbra during focal cerebral ischemia refers to the regions of brain tissue, usually peripheral in location, where blood flow is sufficiently reduced to result in hypoxia severe enough to arrest physiological function, but not so complete as to cause irreversible failure of energy metabolism and cellular necrosis Ginsberg MD. Adventures in the pathophysiology of brain ischeia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis lecture. Stroke. 2003; 34: 214–223

  4. Interventional Treatments for Ischemic Stroke • IV r-tPAis the first line of treatment for ischemic stroke, efficacious and cost-effective for patients with acute ischemic stroke treated up to 4.5h of symptom onset and is relatively ineffective for proximal occlusions • Intra-arterial thrombolysisis more effective for proximal occlusions and can be used up to 6 hours after stroke onset and later in some cases • Thrombectomyis beneficial for about 50% of patients with proximal occlusions

  5. Endovascular Intervention • Intra-arterial Thrombolytic • Mechanical Embolectomy

  6. Why consider IAT • IV rt-PA: • Limited to < 3H • Clear but limitedclinicalbenefit • Rate of recanalisation (doppler): • Complete: 32% • Partial or none 68%: 67% MCA, 25% BA, no ICA (Christou et al 2001)

  7. Why consider IAT • Persistent obstruction persistent deficit • Increase the therapeutic window • Post-operative stroke • Reduce hemorrhagic complications

  8. I.A.T. Theoretical Advantages • Higher concentrations delivered to the clot • Gentle mechanical disruption of the clot • Precise imaging of anatomy, pathology and collateral pattern • Exact degree and timing of recanalisation

  9. I.A.T. Potential Disadvantages • Catheter manipulation • Systemic heparinisation • Delay in initiation of thrombolysis • Skilled facilities • Non cooperative patients

  10. VII. Intra-arterial tPA • < 6 hours for selected patients who are NOT eligible for IV tPA. • Must be at an experienced stroke center with immediate access to angio and interventionalists • IA tPA is reasonable for pts who have contraindications to IV tPA (recent surgery, age, time frame) • Availability of IA tPA should NOT preclude IV tPA in eligible patients

  11. Intra-arterial TPA in stroke • Option for treatmentof selected patients who have major stroke of up to 6 hours durationand with large artery occlusions such as ICA/basilar/MCA and otherwise candidates for IV rtPA (Class I, Level B) • Reasonable in patients who have contraindications to use of IV tPA, such as recent surgery (Class IIa, Level C) • Shouldgenerally not preclude IV tPAin otherwise eligible patients (Class III, Level C)

  12. XII. Endovascular Intervention • Mechanical removal of clot • Clinical trials have shown that thrombectomy with mechanical thrombolysis devices is indeed feasible in the treatment of acute stroke. • Many devices have been discontinued • MERCI Retriever has received FDA clearance. • Catch Retriever system • Penumbra system

  13. Intra-arterial therapy in acute Stroke Merci clot retrieval Penumbra suction device

  14. EMERGING THERAPIESEndovasculartherapies MechanicalThrombectomy 2005 The MERCI Trials : 48 % Recanalization Concentric Retriever device • Smith et al. The MERCI TRIAL Stroke. 2005 Jul; 36(7):1432-8.

  15. Mechanical thrombectomy

  16. Penumbra system

  17. Indications in Anterior Circulation • Persistent occlusion post IV tPA < 3h • Within 6 h,buttime to treatment is correlated with outcome. • IV contra-indicated with evidence of viable tissue: post-op, > 3H • tPA 9 to 40 mg (med 21) • UK 40,000 – 1,500,000 (med 500,000)

  18. Case Study #3 Acute R ICA occlusion Stroke • 50 y.o. female • Acute onset Left hemiparesis and slurred speech • Hx=HTN • Ct done 40 mins after onset • NIHSS=14 • + IV Tpa in 60 min

  19. CT CTA L M1 occlusion

  20. Interventional Treatments for Ischemic Stroke Occlusion L ICA Male 79 IA NIHSS = 19 tPA 5h after onset After thrombectomy complete L ICA recanalization NIHSS = 5 (Demaerschalk and Yip, 2005; The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995

  21. Vertebrobasilar I.A.T. • Time frame: 1 to 48 h after last progression • Most patients present 24-48 h after onset • Only 3 studieswith > 10 patients

  22. Indications in Posterior Circulation • Worsening symptomatology despite heparin • Visualized occlusion • Up to 24h after onset of worsening • UK 250,000-500,000 per H x 2 then 250,000u per H x 4. With heparin. • tPA: 10 mg.

  23. Vertebrobasilar I.A.T.Factorsaffectingoutcome • Infarction of a criticalamount of brainstemtissue • Coma and quadriparesisatpresentation • Lack of recanalization, rethrombosis

More Related